Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Seelos Therapeutics Inc (SEEL)

Seelos Therapeutics Inc (SEEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Psychedelics Offer Hope for Mental Disorders, Addiction

NetworkNewsWire Editorial Coverage : Global destigmatization, changing regulations and an upswing in research are speaking loudly to the opportunity for psychedelics to provide tangible improvements in...

MYCOF : 0.1450 (unch)
MNMD : 1.9100 (-3.54%)
SEEL : 1.6200 (-6.36%)
PSIL : 7.11 (-4.69%)
Seelos Therapeutics Presents a Poster on SLS-002 (Intranasal Racemic Ketamine) at the 2021 IASR/AFSP International Summit on Suicide Research

/PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central...

SEEL : 1.6200 (-6.36%)
Rising Acceptance For Treating Mental Disorders is Fueling Strong Growth in Psychedelic Drugs Market

Palm Beach, FL –October 14, 2021 – FinancialNewsMedia.com News Commentary – Mental disorders are an urgent health crisis worldwide, especially exacerbated by COVID-19. As per a study by Harvard,...

MYCO.NE : 0.185 (-2.63%)
KTTA : 3.30 (-8.59%)
SEEL : 1.6200 (-6.36%)
LKYSF : 0.4800 (-3.63%)
NUMI.VN : 0.590 (-1.67%)
MNMD : 1.9100 (-3.54%)
MYCOF : 0.1450 (unch)
Rising Acceptance For Treating Mental Disorders is Fueling Strong Growth in Psychedelic Drugs Market

/PRNewswire/ -- Mental disorders are an urgent health crisis worldwide, especially exacerbated by COVID-19. As per a study by Harvard, the medical cost of...

KTTA : 3.30 (-8.59%)
SEEL : 1.6200 (-6.36%)
MNMD : 1.9100 (-3.54%)
Why North America Region is Dominating the Billion Dollar Psychedelic Drugs Market

Palm Beach, FL – October 5, 2021 – FinancialNewsMedia.com News Commentary – The psychedelic drugs market is creating major potential for treatment of mental illnesses, and as a result, it is likely...

OPTI.CN : 0.600 (unch)
OPTHF : 0.4700 (-3.25%)
RVVTF : 0.4281 (+1.16%)
RVV.CN : 0.550 (+1.85%)
SEEL : 1.6200 (-6.36%)
LKYSF : 0.4800 (-3.63%)
NUMI.VN : 0.590 (-1.67%)
CMPS : 32.00 (-3.61%)
$10 Billion Sackler Opioid Settlement Closes Chapter, Psychedelic Chapter Begins

FN Media Group Presents Microsmallcap.com Market Commentary

CALM.CN : 0.215 (+2.38%)
SEEL : 1.6200 (-6.36%)
CYBN : 1.4300 (-2.72%)
ATAI : 10.92 (-0.55%)
TNXP : 0.4269 (-9.02%)
Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness

FN Media Group Presents Microsmallcap.com Market Commentary

MMED.NE : 2.450 (-33.42%)
MYCO.NE : 0.185 (-2.63%)
LKYSF : 0.4800 (-3.63%)
SEEL : 1.6200 (-6.36%)
NUMI.VN : 0.590 (-1.67%)
MNMD : 1.9100 (-3.54%)
MYCOF : 0.1450 (unch)
TRYP.CN : 0.235 (-14.55%)
TRYPF : 0.2000 (-4.81%)
Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment

Palm Beach, FL –May 20, 2021 – Sadly, for patients, the pancreatic cancer market has been steadily rising over the past several years and will most likely continue to grow over the next couple of years....

TRIL : 18.44 (+2.62%)
TRIL.TO : 23.33 (+0.47%)
ONCY : 1.5700 (-7.10%)
ONC.TO : 2.03 (-5.14%)
ATNX : 1.6900 (-4.52%)
SEEL : 1.6200 (-6.36%)
MRKR : 1.1700 (-0.85%)
Biotech Companies Driving Psychedelics Industry Forward with Key Research

FN Media Group Presents Microsmallcap.com Market Commentary

MYCO.NE : 0.185 (-2.63%)
MYCOF : 0.1450 (unch)
NUMI.VN : 0.590 (-1.67%)
LKYSF : 0.4800 (-3.63%)
CMPS : 32.00 (-3.61%)
MINE : 0.0001 (unch)
SEEL : 1.6200 (-6.36%)
Seelos Therapeutics Announces Final Data from Phase I PK/PD Study of Intranasal Racemic Ketamine (SLS-002) and Clinical Development Plans

SLS-002 Was Safe and Well Tolerated Across All Doses with Resolution of Expected Group Mean Dissociative Side-Effects That Occurred in the Higher Dose Groups Within One Hour Food and Drug Administration...

SEEL : 1.6200 (-6.36%)

Barchart Exclusives

3 Iron Condor Trade Ideas For December 2nd
An iron condor aims to profit from a drop in implied volatility, with the stock staying within an expected range. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar